EN
EN
FR
ES
PT
AR
RU
DE
IT
NL
TH
KO
VI
ID
Home
Kexing Biopharm
About Us
Kexing Brand
Brand Connotation
Corporate Culture
Honors
History
Global Business
Global Commercial Cooperation Strategy
Commercialization platform
Commercialization capability
Commercial Cooperation Graph
R&D and Innovation
Global R&D Center
R&D field
Animal Vaccine
Synthetic Biology
SANCTINUS
Our Medicines
Infliximab for Injection
Bevacizumab Injection
Adalimumab Solution for Injection
Paclitaxel for Injection(Albumin-Bound)
Human Erythropoietin Injection
Human Granulocyte Colony-stimulating Factor Injection
Combined Clostridium and Bifidobacterium,Live
Human Interferon α1b for Injection
Kehuang Capsule
Entecavir Tablets
α-ketoglutarate(AKG)
5-aminnolevulinic acid (5-ALA)
Recombinant Collagen Repair Mask
Recombinant Collagen Anti-Wrinkle Single Use Essence
Quality Control
Quality system
Compliant production
Pharmacovigilance
ESG
Global health
Support Community
Environmental protection
News
News and information
Video Center
Contact
Contact Us
Join Us
NEWS AND INFORMATION
Home
/
News
/
News and information
/
Kexing Biopharm...
Kexing Biopharm's Product Catalog (Core Product)
Article source：Kexing Biopharm
Jun 17,2025
View： 1704
LABEL:
< Kexing Biopharm's Product Introduction
Kexing Biopharm: A leader in China Recombinant Protein Therapeutics Industry >
BACK TO LIST
Related News
Jun 13,2025
Kexing Biopharm’s GB18 project received clearance of IND application from NMPA and FDA
READ MORE >>
Nov 07,2023
Kexing Biopharm Attended CPHI Worldwide 2023
READ MORE >>
May 08,2025
Why Is Kexing Biopharm the Leading Chinese Biological Products Factory?
READ MORE >>
Dec 31,2024
The Future of Medicine: Exploring Recombinant Protein Drug Suppliers
READ MORE >>
Oct 11,2023
Unveiling the Power of Human Granulocyte Colony Stimulating Factor Injections: Boosting Immune System Health and Recovery
READ MORE >>
Jul 13,2023
The signing & opening ceremony of "Kexing Biopharm - Southeast University Innovation Laboratory for Commercial ...
READ MORE >>
Home
Kexing Biopharm
About Us
Kexing Brand
Brand Connotation
Corporate Culture
Honors
History
Global Business
Global Commercial Cooperation Strategy
Commercialization platform
Commercialization capability
Commercial Cooperation Graph
R&D and Innovation
Global R&D Center
R&D field
Animal Vaccine
Synthetic Biology
SANCTINUS
Our Medicines
Infliximab for Injection
Bevacizumab Injection
Adalimumab Solution for Injection
Paclitaxel for Injection(Albumin-Bound)
Human Erythropoietin Injection
Human Granulocyte Colony-stimulating Factor Injection
Combined Clostridium and Bifidobacterium,Live
Human Interferon α1b for Injection
Kehuang Capsule
Entecavir Tablets
α-ketoglutarate(AKG)
5-aminnolevulinic acid (5-ALA)
Recombinant Collagen Repair Mask
Recombinant Collagen Anti-Wrinkle Single Use Essence
Quality Control
Quality system
Compliant production
Pharmacovigilance
ESG
Global health
Support Community
Environmental protection
News
News and information
Video Center
Contact
Contact Us
Join Us
Article source：Kexing Biopharm
Jun 17,2025
View：
1704 
BACK TO LIST
Jun 13,2025
